Annual EBIT:
-$201.14M-$29.19M(-16.98%)Summary
- As of today, CNTA annual earnings before interest & taxes is -$201.14 million, with the most recent change of -$29.19 million (-16.98%) on December 31, 2024.
- During the last 3 years, CNTA annual EBIT has fallen by -$61.83 million (-44.38%).
- CNTA annual EBIT is now -6258.34% below its all-time high of -$3.16 million, reached on December 31, 2020.
Performance
CNTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$55.30M-$24.40M(-78.99%)Summary
- As of today, CNTA quarterly earnings before interest & taxes is -$55.30 million, with the most recent change of -$24.40 million (-78.99%) on June 1, 2025.
- Over the past year, CNTA quarterly EBIT has dropped by -$11.27 million (-25.60%).
- CNTA quarterly EBIT is now -291.22% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$206.96M-$11.27M(-5.76%)Summary
- As of today, CNTA TTM earnings before interest & taxes is -$206.96 million, with the most recent change of -$11.27 million (-5.76%) on June 1, 2025.
- Over the past year, CNTA TTM EBIT has dropped by -$51.41 million (-33.05%).
- CNTA TTM EBIT is now -815.64% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CNTA EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -17.0% | -25.6% | -33.0% |
3Y3 Years | -44.4% | +18.5% | +2.2% |
5Y5 Years | -3969.2% | -291.2% | -815.6% |
CNTA EBIT Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -44.4% | +4.3% | -79.0% | +25.2% | -33.0% | +6.8% |
5Y | 5-Year | -6258.3% | +4.3% | -291.2% | +25.2% | -815.6% | +6.8% |
All-Time | All-Time | -6258.3% | +4.3% | -291.2% | +25.2% | -815.6% | +6.8% |
CNTA EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$55.30M(-79.0%) | -$206.96M(-5.8%) |
Mar 2025 | - | -$30.90M(+58.2%) | -$195.69M(+2.6%) |
Dec 2024 | -$201.14M(-17.0%) | -$73.89M(-57.6%) | -$200.87M(-23.6%) |
Sep 2024 | - | -$46.88M(-6.5%) | -$162.46M(-4.4%) |
Jun 2024 | - | -$44.03M(-22.1%) | -$155.56M(+2.0%) |
Mar 2024 | - | -$36.07M(-1.6%) | -$158.70M(+7.7%) |
Dec 2023 | -$171.95M(+18.2%) | -$35.48M(+11.2%) | -$171.95M(+3.6%) |
Sep 2023 | - | -$39.98M(+15.3%) | -$178.38M(+4.6%) |
Jun 2023 | - | -$47.17M(+4.4%) | -$187.02M(+9.9%) |
Mar 2023 | - | -$49.32M(-17.7%) | -$207.66M(+0.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$210.15M(-50.8%) | -$41.91M(+13.8%) | -$209.29M(+5.7%) |
Sep 2022 | - | -$48.61M(+28.3%) | -$222.02M(-4.9%) |
Jun 2022 | - | -$67.82M(-33.1%) | -$211.56M(-21.8%) |
Mar 2022 | - | -$50.94M(+6.8%) | -$173.65M(-22.5%) |
Dec 2021 | -$139.31M(-4303.9%) | -$54.65M(-43.3%) | -$141.73M(-143.7%) |
Sep 2021 | - | -$38.14M(-27.5%) | -$58.16M(-190.5%) |
Jun 2021 | - | -$29.92M(-57.3%) | -$20.02M(-302.2%) |
Mar 2021 | - | -$19.02M(-165.8%) | $9.90M(-65.8%) |
Dec 2020 | -$3.16M(+36.0%) | - | - |
Dec 2020 | - | $28.92M | $28.92M |
Dec 2019 | -$4.94M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
- What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?
What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
The current annual EBIT of CNTA is -$201.14M
What is the all-time high annual EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual earnings before interest & taxes is -$3.16M
What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
Over the past year, CNTA annual earnings before interest & taxes has changed by -$29.19M (-16.98%)
What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
The current quarterly EBIT of CNTA is -$55.30M
What is the all-time high quarterly EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
Over the past year, CNTA quarterly earnings before interest & taxes has changed by -$11.27M (-25.60%)
What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
The current TTM EBIT of CNTA is -$206.96M
What is the all-time high TTM EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?
Over the past year, CNTA TTM earnings before interest & taxes has changed by -$51.41M (-33.05%)